Search - tctmd.com

Displaying 781 - 800 of 4251

Sort: Relevancy | Date

News Industry News

GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains FDA Approval

February 10, 2016

Presentation JIM 2016

CoreValve Evolut R: Setting New Standards in TAVI Without Compromise

Presenter: Ganesh Manoharan

February 10, 2016

Presentation JIM 2016

ACURATE Neo: Top-down deployment translates into stable, precise positioning and successful procedures: Symetis TAVI programme highlights

Presenter: Christian Hengstenberg

February 10, 2016

Presentation JIM 2016

SAPIEN 3: Current Experience

Presenter: Martin B. Leon

February 09, 2016

News Industry News

First Patient Treated with Medtronic Valiant TAAA Stent Graft System in Thoracoabdominal Aortic Aneurysm Study

February 09, 2016

News Daily News

在 TAVR 患者中观察到瓣膜血流动力学的亚临床变化

Michael O'Riordan

February 08, 2016

News Daily News

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Michael O'Riordan

February 08, 2016

News Daily News

Se Observan Cambios Subclínicos en la Hemodinámica Valvular en Pacientes TAVR

Michael O'Riordan

February 08, 2016

Presentation ISET 2016

Early Experiences with an off the Shelf Arch Endograft and the Only Unilateral AAA Endograft

Presenter: Ross Milner

February 08, 2016

News Conference News ISET 2016

‘Encouraging’ Early Findings With Embolic Protection in TEVAR, Suggests Small Pilot Study

Michael O'Riordan

February 08, 2016

News Daily News

研究确定患者使用 Sapien 3 出现新传导异常、需要心脏起搏器置入的预测因素

L.A. McKeown

February 07, 2016

News Daily News

Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3

L.A. McKeown

February 07, 2016

Presentation

Incidence, Timing, and Predictors of Valve Hemodynamic Deterioration After TAVR

Presenter: M. Del Trigo

February 07, 2016

Presentation ISET 2016

Extreme TAVR: What Are the Limits and the Future?

Presenter: Eberhard Grube

February 06, 2016

Presentation ISET 2016

Current Indications for TAVR Therapy: Are They Different in the United States and Europe?

Presenter: Eberhard Grube

February 06, 2016

Presentation Scripps 2016

When TAVR Goes Bad: Dealing with Complications

Presenter: Curtiss T. Stinis

February 04, 2016

Presentation

Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With Sapien 3

Presenter: Oliver Husser

February 04, 2016

Presentation Scripps 2016

TAVR - now a mainstream therapy

Presenter: Michael J. Mack

February 03, 2016

Presentation Scripps 2016

Selecting the Optimal Patient for TAVR: What Does the Current Data Tell Us?

Presenter: Susheel Kodali

February 03, 2016

Presentation Scripps 2016

PVL Closure: Keys to Success

Presenter: Paul Sorajja

February 03, 2016

Advertisement

GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains FDA Approval

CoreValve Evolut R: Setting New Standards in TAVI Without Compromise

ACURATE Neo: Top-down deployment translates into stable, precise positioning and successful procedures: Symetis TAVI programme highlights

SAPIEN 3: Current Experience

First Patient Treated with Medtronic Valiant TAAA Stent Graft System in Thoracoabdominal Aortic Aneurysm Study

在 TAVR 患者中观察到瓣膜血流动力学的亚临床变化

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Se Observan Cambios Subclínicos en la Hemodinámica Valvular en Pacientes TAVR

Early Experiences with an off the Shelf Arch Endograft and the Only Unilateral AAA Endograft

‘Encouraging’ Early Findings With Embolic Protection in TEVAR, Suggests Small Pilot Study

研究确定患者使用 Sapien 3 出现新传导异常、需要心脏起搏器置入的预测因素

Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3

Incidence, Timing, and Predictors of Valve Hemodynamic Deterioration After TAVR

Extreme TAVR: What Are the Limits and the Future?

Current Indications for TAVR Therapy: Are They Different in the United States and Europe?

When TAVR Goes Bad: Dealing with Complications

Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With Sapien 3

TAVR - now a mainstream therapy

Selecting the Optimal Patient for TAVR: What Does the Current Data Tell Us?

PVL Closure: Keys to Success

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content